NCT04516382View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

January 12, 2021

Study Completion Date

June 30, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

PTG-300

Active drug

Trial Locations (1)

Unknown

Protagonist Clinical Center, Melbourne

All Listed Sponsors
lead

Protagonist Therapeutics, Inc.

INDUSTRY

NCT04516382 - Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers | Biotech Hunter | Biotech Hunter